dc.creator | Abubakar, Usman | es |
dc.creator | Al-Anazi, Menier | es |
dc.creator | Alanazi, Zainab | es |
dc.creator | Rodríguez-Baño, Jesús | es |
dc.date.accessioned | 2023-04-17T13:52:41Z | |
dc.date.available | 2023-04-17T13:52:41Z | |
dc.date.issued | 2022-12-28 | |
dc.identifier.citation | Abubakar, U., Al-Anazi, M., Alanazi, Z. y Rodríguez-Baño, J. (2022). Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2022.12.022. | |
dc.identifier.issn | 1876-0341 | es |
dc.identifier.uri | https://hdl.handle.net/11441/144509 | |
dc.description.abstract | Background: There is paucity of data describing the impact of COVID-19 pandemic on antimicrobial resistance.
This review evaluated the changes in the rate of multidrug resistant gram negative and gram
positive bacteria during the COVID-19 pandemic.
Methods: A search was conducted in PubMed, Science Direct, and Google Scholar databases to identify
eligible studies. Studies that reported the impact of COVID-19 pandemic on carbapenem-resistant
Acinetobacter baumannii (CRAB), carbapenem-resistant Enterobacteriaceae (CRE), extended-spectrum betalactamase
inhibitor (ESBL)-producing Enterobacteriaceae, vancomycin-resistant enterococci (VRE), methicillin-
resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Pseudomonas aeruginosa (CPE) were
selected. Studies published in English language from the start of COVID-19 pandemic to July 2022 were
considered for inclusion.
Results: Thirty eligible studies were selected and most of them were from Italy (n = 8), Turkey (n = 3) and
Brazil (n = 3). The results indicated changes in the rate of multidrug resistant bacteria, and the changes
varied between the studies. Most studies (54.5%) reported increase in MRSA infection/colonization during
the pandemic, and the increase ranged from 4.6 to 170.6%. Five studies (55.6%) reported a 6.8–65.1% increase
in VRE infection/colonization during the pandemic. A 2.4–58.2% decrease in ESBL E. coli and a 1.8–13.3%
reduction in ESBL Klebsiella pneumoniae was observed during the pandemic. For CRAB, most studies (58.3%)
reported 1.5–621.6% increase in infection/colonization during the pandemic. Overall, studies showed increase
in the rate of CRE infection/colonization during the pandemic. There was a reduction in carbapenemresistant
E. coli during COVID-19 pandemic, and an increase in carbapenem-resistant K. pneumoniae. Most
studies (55.6%) showed 10.4 – 40.9% reduction in the rate of CRPA infection during the pandemic.
Conclusion: There is an increase in the rate of multidrug resistant gram positive and gram negative bacteria
during the COVID-19 pandemic. However, the rate of ESBL-producing Enterobacteriaceae and CRPA has
decrease during the pandemic. Both infection prevention and control strategies and antimicrobial stewardship
should be strengthen to address the increasing rate of multidrug resistant gram positive and gram
negative bacteria. | es |
dc.format | application/pdf | es |
dc.format.extent | 12 p. | |
dc.language.iso | eng | es |
dc.publisher | Elsevier | es |
dc.relation.ispartof | Journal of Infection and Public Health. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Antimicrobial resistance | es |
dc.subject | COVID-19 pandemic | es |
dc.subject | MRSA | es |
dc.subject | Carbapenem-resistant enterobacteriacea | es |
dc.subject | Vancomycin-resistant enterococci | es |
dc.subject | Impact | es |
dc.subject | Gram positive | es |
dc.subject | Gram negative | es |
dc.title | Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Cirugía | es |
dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S1876034122003720?via%3Dihub | es |
dc.identifier.doi | 10.1016/j.jiph.2022.12.022 | es |
dc.journaltitle | Journal of Infection and Public Health | es |
dc.publication.volumen | 16 | |
dc.publication.issue | 3 | |
dc.publication.initialPage | 320 | |
dc.publication.endPage | 331 | |
dc.publication.endPage | | |